Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension

Sodium-glucose transporter 2 (SGLT2) inhibitors are new glucose-lowering agents that have been proven to be beneficial for patients with cardiovascular diseases, heart failure, and sudden cardiac death. However, the possible protective effects of cardiac arrhythmia have not yet been clarified in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhuo, Shih-Jie, Lin, Tsung-Hsien, Lin, Yi-Hsiung, Tsai, Wei-Chung, Liu, I-Hsin, Wu, Bin-Nan, Lee, Kun-Tai, Lai, Wen-Ter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880188/
https://www.ncbi.nlm.nih.gov/pubmed/35207759
http://dx.doi.org/10.3390/jpm12020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880188/
https://www.ncbi.nlm.nih.gov/pubmed/35207759
http://dx.doi.org/10.3390/jpm12020271

Ejemplares similares